EGFR mutation types and abundance were associated with the overall survival of advanced lung adenocarcinoma patients receiving first-line tyrosine kinase inhibitors
Article in Journal of Thoracic Disease (June 2022)
The most recent citing publications are shown below. View all 42 publications that cite this research output on Dimensions.
Article in Journal of Thoracic Disease (June 2022)
Article in International Journal of Cancer (April 2018)
Article in Indian Journal of Surgical Oncology (December 2016)